Vaccine Blurbs Issue 129: New Temperature Log Reporting Option Coming Soon!

p3

Washington State Department of Health | March 15, 2022


Join Us For Next CVP Training Session

March 17, 2022 12:00-12:30PM

CVP Training Series: WVA Billing & Eligibility

Visit our webpage to view previously recorded training sessions, get additional training resources, and to see what topics are coming up next:

April 21, 2022 – CVP Training Series: Ordering Basics


New Temperature Log Reporting Option beginning April 1, 2022!

Starting April 1, the Childhood Vaccine Program (CVP) will begin accepting monthly temperature summary reports from Digital Data Loggers (DDL) and Temperature Monitoring Systems (TMS), upon program approval. Providers wishing to obtain approval must submit a copy of their report to the program at WAChildhoodVaccines@doh.wa.gov for review.   

To be considered for approval, DDL and TMS summary reports must contain the following as required by CDC’s Vaccines for Children Program: 

  • Min/max temperature check once per day 
  • Time and date of reading 
  • Name or initials of staff member who recorded the reading  

Sample TMS that meets criteria:  

 

DDL summary report

Why are we making this change?  

On April 1, 2022 the COVID Vaccine Program will begin requiring providers to submit monthly temperature logs in either handwritten paper form or DDL/TMS summary reports. While this is a new requirement for COVID vaccine providers, the Childhood Vaccine Program has had a temperature reporting requirement for many years. We are making this change to align with COVID vaccine reporting options, while still meeting the CDC’s requirements for the Vaccine for Children program. Providers whose DDL or TMS reports do not meet the reporting requirements listed above must continue to submit monthly paper temperature logs.  

Monitoring vaccine storage equipment and temperatures are daily responsibilities to ensure the viability of your vaccine supply and the safety of your patients.  Implementing routine monitoring activities can help you identify temperature excursions quickly and take immediate action to correct them, preventing loss of vaccines and the potential need for revaccination of patients. 

Please contact WAChildhoodVaccines@DOH.WA.GOV with questions. 


Immunization Barriers During COVID-19 Pandemic

Childhood and adolescent immunization rates have remained low compared to pre-pandemic rates even after the stay at home order was lifted. The Office of Immunization created a survey to get feedback from immunization providers on barriers to routine pediatric and adolescent vaccines. It should take approximately 5 minutes to complete and would help us to understand factors that might be contributing. Please complete the survey by Friday, March 25th.

Here is the link to the survey.

For any questions or feedback, please email immunizewa@doh.wa.gov.


Join the IACW Quarterly Meeting

The IACW quarterly meeting will be held on April 27, 2022, the same time as National Infant Immunization Week. National Infant Immunization Week (NIIW) is a yearly observance highlighting the importance of protecting children two years and younger from vaccine-preventable diseases (VPDs). This year, in particular, it’s critical to ensure that families stay on track for children’s routine checkups and recommended vaccinations — even during COVID-19.

We are honored to have UW Medicine present a new campaign “One Vax Two Lives” to dispel COVID-19 vaccine misinformation for pregnant and breastfeeding individuals. This group continues to make inroads into vaccine hesitancy related to women's health issues including menstruation, fertility and safety in pregnancy and breastfeeding. Also, there is a panel to discuss challenges in vaccinating infant and pregnant women, promoting COVID-19 vaccines among pregnant women, and vaccine access/barriers experienced among this population and resources.

Highlight:
• When Vaccine Misinformation Targets Women’s Reproductive Health and Pregnancy: Fighting Back with the One Vax Two Lives Campaign
• Panel on increasing awareness about vaccinations for Pregnancy and infants


Order Laminated Immunization Schedules

2022 immunization schedules

Immunize​.org’s laminated schedules for children and adults are available for order. These laminated schedules are great for any busy healthcare setting where vaccinations are given since they can be wiped down and durable enough to stand up to a year's worth of use. The laminated schedules are now published in a standard 8.5” X 11” booklet format. The child/adolescent schedule is a total of five double-sided pages and includes a 1-page handout summarizing the dose, route, and needle size recommendations.


Clinical Corner

School and Child Care Immunization Requirements Webinar on March 30

Register for the training here. The Department of Health is hosting an Immunization Schedule and School and Child Care Immunization Requirements webinar on Wednesday, March 30, at 12:00 PM PT. The presenters will review the 2022 immunization schedule and go over school and child care requirements for the 2022-2023 school year. Continuing education will be offered for nurses and medical assistants, and we are applying for CE for pharmacists/pharmacy technicians. The presentation will be recorded and available at a later date.

Learning objectives:

  1. Identify updates to the 2022 immunization schedule.
  2. Describe the immunization requirements needed to attend school and child care in Washington state.
  3. Identify the changes to the requirements from previous school years.
  4. Know where to find relevant immunization resources.

For questions about CEs, slides, and recording info, check out the webinar web page.


Pneumococcal Conjugate Vaccines

The Advisory Committee on Immunization Practices (ACIP) is considering the use of PCV15 (Vaxneuvance, Merck) in children as an alternative to PCV13. PCV15 is expected to be approved by the Food and Drug Administration (FDA) for use in children in April 2022, with FDA approval of PCV20 (Prevnar20, Pfizer) possibly in mid-2023. ACIP currently recommends PCV13 for routine and catch-up vaccination, and a series of PCV13 plus PPSV23 for children age 24 months or older with certain underlying medical conditions. PCV15 vaccine contains the serotypes found in PCV13, with the addition of serotypes 22F and 33F, which cause 8–17% of remaining pneumococcal disease in children younger than age 5 years. ACIP is not considering a change to the recommended pneumococcal vaccination dosing or schedule. ACIP is expected to vote on PCV15 for children during its June 2022 meeting.


Dengue Vaccine Recommended for Certain Children 

In May 2019, Dengvaxia® became the first dengue vaccine to be approved by the Food and Drug Administration (FDA). The FDA approved its use for children 9 to 16 years old with laboratory-confirmed previous dengue virus infection and who live in an area with endemic dengue. Endemic areas include Puerto Rico, American Samoa, US Virgin Islands, Federated States of Micronesia, Republic of Marshall Islands, and the Republic of Palau. ACIP recommended use of Dengvaxia in June 2021 and vaccine recommendations can be found in the 2022 Child and Adolescent Immunization Schedule.


For questions about the immunization schedule, the Immunization Information System forecast, or any other immunization clinical questions, please send an email to ImmuneNurses@doh.wa.gov. Check out the Immunization Training web page for more resources and training opportunities.


Helpful Hints

Provider Agreement Renewals Are Underway

The annual Childhood Vaccine Provider Agreement renewal period is underway. Please take this time to renew your provider agreement to continue to receive publicly funded vaccines. We have many resources available to assist you in the renewal process including: 

Renewal Schedule

Renewal Guide

Renewal FAQ

Pre-Recorded Webinar